| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | benzoate-CoA ligase activity | 1.11e-05 | 3 | 39 | 2 | GO:0018858 | |
| GeneOntologyMolecularFunction | decanoate-CoA ligase activity | 2.22e-05 | 4 | 39 | 2 | GO:0102391 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 2.86e-05 | 465 | 39 | 7 | GO:0046873 | |
| GeneOntologyMolecularFunction | D-glucose:sodium symporter activity | 7.76e-05 | 7 | 39 | 2 | GO:0005412 | |
| GeneOntologyMolecularFunction | fatty-acyl-CoA synthase activity | 1.03e-04 | 8 | 39 | 2 | GO:0004321 | |
| GeneOntologyMolecularFunction | calcium channel activity | 1.15e-04 | 129 | 39 | 4 | GO:0005262 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 1.87e-04 | 627 | 39 | 7 | GO:0022890 | |
| GeneOntologyMolecularFunction | medium-chain fatty acid-CoA ligase activity | 2.02e-04 | 11 | 39 | 2 | GO:0031956 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 2.10e-04 | 151 | 39 | 4 | GO:0015085 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 2.65e-04 | 664 | 39 | 7 | GO:0008324 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | 3.60e-04 | 1180 | 39 | 9 | GO:0022857 | |
| GeneOntologyMolecularFunction | carbohydrate:monoatomic cation symporter activity | 4.96e-04 | 17 | 39 | 2 | GO:0005402 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 5.88e-04 | 758 | 39 | 7 | GO:0015318 | |
| GeneOntologyMolecularFunction | transporter activity | 6.87e-04 | 1289 | 39 | 9 | GO:0005215 | |
| GeneOntologyMolecularFunction | C-acyltransferase activity | 7.62e-04 | 21 | 39 | 2 | GO:0016408 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 7.68e-04 | 793 | 39 | 7 | GO:0015075 | |
| GeneOntologyMolecularFunction | D-glucose transmembrane transporter activity | 1.08e-03 | 25 | 39 | 2 | GO:0055056 | |
| GeneOntologyMolecularFunction | hexose transmembrane transporter activity | 1.08e-03 | 25 | 39 | 2 | GO:0015149 | |
| GeneOntologyMolecularFunction | fatty acid ligase activity | 1.17e-03 | 26 | 39 | 2 | GO:0015645 | |
| GeneOntologyMolecularFunction | CoA-ligase activity | 1.27e-03 | 27 | 39 | 2 | GO:0016405 | |
| GeneOntologyMolecularFunction | monosaccharide transmembrane transporter activity | 1.27e-03 | 27 | 39 | 2 | GO:0015145 | |
| GeneOntologyMolecularFunction | sugar transmembrane transporter activity | 1.46e-03 | 29 | 39 | 2 | GO:0051119 | |
| GeneOntologyMolecularFunction | acid-thiol ligase activity | 1.67e-03 | 31 | 39 | 2 | GO:0016878 | |
| GeneOntologyMolecularFunction | steroid hydroxylase activity | 2.00e-03 | 34 | 39 | 2 | GO:0008395 | |
| GeneOntologyMolecularFunction | ligase activity, forming carbon-sulfur bonds | 2.90e-03 | 41 | 39 | 2 | GO:0016877 | |
| GeneOntologyMolecularFunction | carbohydrate transmembrane transporter activity | 3.05e-03 | 42 | 39 | 2 | GO:0015144 | |
| GeneOntologyMolecularFunction | molecular condensate scaffold activity | 3.05e-03 | 42 | 39 | 2 | GO:0140693 | |
| GeneOntologyMolecularFunction | demethylase activity | 3.34e-03 | 44 | 39 | 2 | GO:0032451 | |
| GeneOntologyMolecularFunction | vitamin binding | 3.80e-03 | 161 | 39 | 3 | GO:0019842 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | 4.13e-03 | 49 | 39 | 2 | GO:0016712 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 4.38e-03 | 343 | 39 | 4 | GO:0005261 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 4.50e-03 | 171 | 39 | 3 | GO:0015081 | |
| GeneOntologyMolecularFunction | ligase activity | 4.72e-03 | 174 | 39 | 3 | GO:0016874 | |
| GeneOntologyMolecularFunction | pyridoxal phosphate binding | 5.36e-03 | 56 | 39 | 2 | GO:0030170 | |
| GeneOntologyMolecularFunction | carbon-carbon lyase activity | 5.36e-03 | 56 | 39 | 2 | GO:0016830 | |
| GeneOntologyMolecularFunction | vitamin B6 binding | 5.54e-03 | 57 | 39 | 2 | GO:0070279 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 6.38e-03 | 194 | 39 | 3 | GO:0016705 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 6.56e-03 | 614 | 39 | 5 | GO:0140657 | |
| GeneOntologyMolecularFunction | lyase activity | 8.14e-03 | 212 | 39 | 3 | GO:0016829 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 1.09e-02 | 81 | 39 | 2 | GO:0015370 | |
| GeneOntologyMolecularFunction | acyltransferase activity, transferring groups other than amino-acyl groups | 1.11e-02 | 238 | 39 | 3 | GO:0016747 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 1.20e-02 | 459 | 39 | 4 | GO:0005216 | |
| GeneOntologyMolecularFunction | magnesium ion binding | 1.23e-02 | 247 | 39 | 3 | GO:0000287 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 1.37e-02 | 477 | 39 | 4 | GO:0022804 | |
| GeneOntologyMolecularFunction | chromatin binding | 1.39e-02 | 739 | 39 | 5 | GO:0003682 | |
| GeneOntologyMolecularFunction | histone binding | 1.49e-02 | 265 | 39 | 3 | GO:0042393 | |
| GeneOntologyBiologicalProcess | mycotoxin metabolic process | 9.68e-05 | 8 | 39 | 2 | GO:0043385 | |
| GeneOntologyBiologicalProcess | aflatoxin metabolic process | 9.68e-05 | 8 | 39 | 2 | GO:0046222 | |
| GeneOntologyBiologicalProcess | organic heteropentacyclic compound metabolic process | 9.68e-05 | 8 | 39 | 2 | GO:1901376 | |
| GeneOntologyBiologicalProcess | inorganic ion import across plasma membrane | 1.47e-04 | 142 | 39 | 4 | GO:0099587 | |
| GeneOntologyBiologicalProcess | inorganic cation import across plasma membrane | 1.47e-04 | 142 | 39 | 4 | GO:0098659 | |
| Domain | RBR | 8.42e-09 | 3 | 39 | 3 | PF17208 | |
| Domain | SCML2_RBR | 8.42e-09 | 3 | 39 | 3 | IPR033763 | |
| Domain | SLED | 8.39e-08 | 5 | 39 | 3 | IPR021987 | |
| Domain | SLED | 8.39e-08 | 5 | 39 | 3 | PF12140 | |
| Domain | SAM_1 | 1.20e-05 | 68 | 39 | 4 | PF00536 | |
| Domain | TRPM_tetra | 2.54e-05 | 4 | 39 | 2 | PF16519 | |
| Domain | TRPM_tetra | 2.54e-05 | 4 | 39 | 2 | IPR032415 | |
| Domain | SAM_DOMAIN | 4.51e-05 | 95 | 39 | 4 | PS50105 | |
| Domain | SAM | 4.89e-05 | 97 | 39 | 4 | IPR001660 | |
| Domain | - | 6.92e-05 | 106 | 39 | 4 | 1.10.150.50 | |
| Domain | Ion_trans_dom | 9.18e-05 | 114 | 39 | 4 | IPR005821 | |
| Domain | Ion_trans | 9.18e-05 | 114 | 39 | 4 | PF00520 | |
| Domain | SAM/pointed | 1.02e-04 | 117 | 39 | 4 | IPR013761 | |
| Domain | Na/solute_symporter_CS | 1.18e-04 | 8 | 39 | 2 | IPR018212 | |
| Domain | Pyridoxal_deC | 1.18e-04 | 8 | 39 | 2 | PF00282 | |
| Domain | DDC_GAD_HDC_YDC | 1.18e-04 | 8 | 39 | 2 | PS00392 | |
| Domain | PyrdxlP-dep_de-COase | 1.18e-04 | 8 | 39 | 2 | IPR002129 | |
| Domain | MBT | 1.52e-04 | 9 | 39 | 2 | SM00561 | |
| Domain | MBT | 1.52e-04 | 9 | 39 | 2 | PS51079 | |
| Domain | MBT | 1.89e-04 | 10 | 39 | 2 | PF02820 | |
| Domain | Mbt | 1.89e-04 | 10 | 39 | 2 | IPR004092 | |
| Domain | NA_SOLUT_SYMP_2 | 2.77e-04 | 12 | 39 | 2 | PS00457 | |
| Domain | SSF | 2.77e-04 | 12 | 39 | 2 | PF00474 | |
| Domain | Na/solute_symporter | 2.77e-04 | 12 | 39 | 2 | IPR001734 | |
| Domain | NA_SOLUT_SYMP_3 | 2.77e-04 | 12 | 39 | 2 | PS50283 | |
| Domain | AMP-bd_C | 5.66e-04 | 17 | 39 | 2 | IPR025110 | |
| Domain | AMP-binding_C | 5.66e-04 | 17 | 39 | 2 | PF13193 | |
| Domain | SAM | 8.17e-04 | 88 | 39 | 3 | SM00454 | |
| Domain | AMP-binding_CS | 1.34e-03 | 26 | 39 | 2 | IPR020845 | |
| Domain | AMP_BINDING | 1.55e-03 | 28 | 39 | 2 | PS00455 | |
| Domain | AMP-binding | 1.78e-03 | 30 | 39 | 2 | PF00501 | |
| Domain | AMP-dep_Synth/Lig | 1.78e-03 | 30 | 39 | 2 | IPR000873 | |
| Domain | - | 3.00e-03 | 39 | 39 | 2 | 3.40.640.10 | |
| Domain | PyrdxlP-dep_Trfase | 3.31e-03 | 41 | 39 | 2 | IPR015424 | |
| Domain | PyrdxlP-dep_Trfase_major_sub1 | 3.31e-03 | 41 | 39 | 2 | IPR015421 | |
| Domain | Cyt_P450_E_grp-I | 3.97e-03 | 45 | 39 | 2 | IPR002401 | |
| Domain | Cyt_P450_CS | 5.47e-03 | 53 | 39 | 2 | IPR017972 | |
| Domain | CYTOCHROME_P450 | 6.31e-03 | 57 | 39 | 2 | PS00086 | |
| Domain | - | 6.52e-03 | 58 | 39 | 2 | 1.10.630.10 | |
| Domain | p450 | 6.52e-03 | 58 | 39 | 2 | PF00067 | |
| Domain | Cyt_P450 | 6.97e-03 | 60 | 39 | 2 | IPR001128 | |
| Pathway | REACTOME_TRP_CHANNELS | 4.40e-05 | 28 | 35 | 3 | MM14943 | |
| Pathway | REACTOME_TRP_CHANNELS | 4.40e-05 | 28 | 35 | 3 | M27241 | |
| Pathway | REACTOME_CONJUGATION_OF_SALICYLATE_WITH_GLYCINE | 8.93e-05 | 6 | 35 | 2 | MM14693 | |
| Pathway | REACTOME_AMINO_ACID_CONJUGATION | 1.25e-04 | 7 | 35 | 2 | MM14598 | |
| Pathway | REACTOME_DRUG_ADME | 1.47e-04 | 109 | 35 | 4 | M45012 | |
| Pathway | REACTOME_AMINO_ACID_CONJUGATION | 2.13e-04 | 9 | 35 | 2 | M26968 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 21278253 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 16521160 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 19634011 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 29948332 | ||
| Pubmed | Mapping the expression of transient receptor potential channels across murine placental development. | 2.60e-06 | 24 | 39 | 3 | 33884443 | |
| Pubmed | 2.95e-06 | 25 | 39 | 3 | 16382100 | ||
| Pubmed | 3.74e-06 | 27 | 39 | 3 | 16460286 | ||
| Pubmed | 6.95e-06 | 33 | 39 | 3 | 19834762 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 22211741 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 32830538 | ||
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 16857711 | ||
| Pubmed | 1.67e-05 | 44 | 39 | 3 | 19322198 | ||
| Pubmed | Etomoxir regulates the differentiation of male germ cells by specifically reducing H3K27ac level. | 2.56e-05 | 7 | 39 | 2 | 33517883 | |
| Pubmed | 5.48e-05 | 10 | 39 | 2 | 15752708 | ||
| Pubmed | Pazopanib-induced hyperbilirubinemia is associated with Gilbert's syndrome UGT1A1 polymorphism. | 6.70e-05 | 11 | 39 | 2 | 20389299 | |
| Pubmed | A trimeric Rab7 GEF controls NPC1-dependent lysosomal cholesterol export. | 7.45e-05 | 392 | 39 | 5 | 33144569 | |
| Pubmed | Dynamic expression of the TRPM subgroup of ion channels in developing mouse sensory neurons. | 8.03e-05 | 12 | 39 | 2 | 19850157 | |
| Pubmed | 1.11e-04 | 14 | 39 | 2 | 19933188 | ||
| Pubmed | Loss of miR-17~92 results in dysregulation of Cftr in nephron progenitors. | 1.65e-04 | 17 | 39 | 2 | 30838872 | |
| Pubmed | Genome-wide meta-analysis identifies six novel loci associated with habitual coffee consumption. | 1.85e-04 | 18 | 39 | 2 | 25288136 | |
| Pubmed | 2.30e-04 | 20 | 39 | 2 | 21072184 | ||
| Pubmed | 2.30e-04 | 20 | 39 | 2 | 19751749 | ||
| Pubmed | Evolutionarily-conserved MZIP2 is essential for crossover formation in mammalian meiosis. | 2.54e-04 | 21 | 39 | 2 | 30272023 | |
| Pubmed | 3.62e-04 | 25 | 39 | 2 | 19372376 | ||
| Pubmed | 5.87e-04 | 613 | 39 | 5 | 22268729 | ||
| Pubmed | 7.19e-04 | 156 | 39 | 3 | 32850835 | ||
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 8.40e-04 | 38 | 39 | 2 | 30786075 | |
| Pubmed | PCGF homologs, CBX proteins, and RYBP define functionally distinct PRC1 family complexes. | 9.77e-04 | 41 | 39 | 2 | 22325352 | |
| Pubmed | 1.02e-03 | 399 | 39 | 4 | 37536630 | ||
| Interaction | ACSM2A interactions | 2.18e-05 | 4 | 39 | 2 | int:ACSM2A | |
| Interaction | ACSM2B interactions | 2.18e-05 | 4 | 39 | 2 | int:ACSM2B | |
| Cytoband | 16p12.3 | 3.88e-04 | 34 | 39 | 2 | 16p12.3 | |
| GeneFamily | Sterile alpha motif domain containing | 1.30e-05 | 88 | 30 | 4 | 760 | |
| GeneFamily | Transient receptor potential cation channels | 1.31e-05 | 28 | 30 | 3 | 249 | |
| GeneFamily | Sterile alpha motif domain containing|MBT domain containing | 9.51e-05 | 9 | 30 | 2 | 1263 | |
| GeneFamily | Acyl-CoA synthetase family | 8.44e-04 | 26 | 30 | 2 | 40 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.22e-08 | 183 | 39 | 6 | 85446581999cd66b171c4f69b7eb8b0bbbaa8617 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.11e-07 | 173 | 39 | 5 | 8888434641ea554a9b62c436e87920378eef29cd | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.47e-07 | 176 | 39 | 5 | 1595dbeee336a81e581325d63208ec6262664ee9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.60e-07 | 177 | 39 | 5 | 2f81b26be89cc2fd8eafadaf7eae3c6ad6521462 | |
| ToppCell | COVID-19-kidney-PCT-S1/S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.73e-07 | 178 | 39 | 5 | 23a12d3d971b857d5be8e907334d1f6b49eeeb32 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.86e-07 | 179 | 39 | 5 | 58ae5a97fe2a14e1c6fdeb886397eb06fdaf0428 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.86e-07 | 179 | 39 | 5 | d1ef7e1cb00336118e387b47f4f8120f53584391 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.28e-07 | 182 | 39 | 5 | e1e58176f533092b6b974ca1ce8b02192a6e193d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.28e-07 | 182 | 39 | 5 | 4a9c13932e7163fd37a3dcc4c6ca3bbea5372459 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.28e-07 | 182 | 39 | 5 | 57bb5a2da976464ba7c4460106bd9f692008ebd9 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.42e-07 | 183 | 39 | 5 | d73cac83cde82665f110baad7cf28db75f9ffe52 | |
| ToppCell | COVID-19-kidney-PCT-S1/S2|kidney / Disease (COVID-19 only), tissue and cell type | 5.57e-07 | 184 | 39 | 5 | dc71f22583fc54b89b242cbb602f4bbe86f576ec | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.57e-07 | 184 | 39 | 5 | 9434731f651820b05335085582960f08fbf895de | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.88e-07 | 186 | 39 | 5 | a417e1e21313a7e05951038cdef5ac672a9f727c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.88e-07 | 186 | 39 | 5 | 5784d255e9ca449d375d81938d0fbbd8a7eb44f6 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.04e-07 | 187 | 39 | 5 | 1b82920588f9e26ef1db244d452736d75fcfd342 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.04e-07 | 187 | 39 | 5 | c1e4c0345f9bfa0538730bad5ff3fa5240168b25 | |
| ToppCell | Endothelial-B-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 6.20e-07 | 188 | 39 | 5 | ecb74d67314a43b5805b7f2a7bb9ff6c5a60200a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.70e-07 | 191 | 39 | 5 | 3c464645d0e7e423f791bd63bf5bcf11f6b590d3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.70e-07 | 191 | 39 | 5 | 1c1d13144259b998d4a0e85142f7afef2ef1e63f | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.87e-07 | 192 | 39 | 5 | 3e1a4cb0d83efd502c8613d41a1692bdda5860ed | |
| ToppCell | TCGA-Kidney|World / Sample_Type by Project: Shred V9 | 9.15e-06 | 151 | 39 | 4 | e31974c0d0a0c644205a0ee6013ab74a09d8a306 | |
| ToppCell | Endothelial-B-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 1.33e-05 | 166 | 39 | 4 | c286987ea4e511195607c87ec4529c2c2ed2122e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-05 | 168 | 39 | 4 | fa0d251693935116adf633d02b7ec4a295100865 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.43e-05 | 169 | 39 | 4 | 6937c46b119d4ce382fc8c2fa5925ede5ae89c81 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-mesothelial_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.43e-05 | 169 | 39 | 4 | 0cece9b2bb1f58e465c20ec8735a4fc3c1021f03 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.49e-05 | 171 | 39 | 4 | f5014e3c387fe3118944af392abe10d6b9b0abab | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D122|Adult / Lineage, Cell type, age group and donor | 1.56e-05 | 173 | 39 | 4 | dba09ba9748871e38a16449d500ae4d7b405c42f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.79e-05 | 179 | 39 | 4 | 78fae47ec9bff4e0159a86a281e831d7f8ee925a | |
| ToppCell | COPD-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class | 1.79e-05 | 179 | 39 | 4 | e816dd846a6918ec143b57a380c3a47ed073b66e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-05 | 180 | 39 | 4 | f8bdfd7bf7b3d52c659a29d8f5f80858e79da83e | |
| ToppCell | COVID-19-kidney-tDL|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.83e-05 | 180 | 39 | 4 | 864c895b5eaedefae86f5829fa344f7b686fb59f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-05 | 180 | 39 | 4 | 1363b3254470f6ff98630d1df83a1bdbacc137e0 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.87e-05 | 181 | 39 | 4 | 9542c19edc9bd2cba68c01c2a8407705398e3011 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.87e-05 | 181 | 39 | 4 | 8f04f8cac5d705dc5f6cf6f4516d6e45b0aa4ae5 | |
| ToppCell | COVID-19-kidney-Stressed_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.87e-05 | 181 | 39 | 4 | 6980ea624151da32b7f537f263e40fcb87a02e81 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-mesothelial_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.95e-05 | 183 | 39 | 4 | c5caac6ed6c8d67f5c336281d9fd903976509445 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-05 | 183 | 39 | 4 | facd6dbe0851b537d70a899ac7485714ab27d071 | |
| ToppCell | COVID-19-kidney-PCT-S1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.95e-05 | 183 | 39 | 4 | 6878d14026c3df6aa12e45dfad94b32fa9d9b0b7 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-05 | 183 | 39 | 4 | 84b64cf728629c3af9a8d2ed15b93adf562c54b8 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.95e-05 | 183 | 39 | 4 | 9d5a363fbe6f0a1668c9d584df65ee1c283349c7 | |
| ToppCell | COVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type | 1.99e-05 | 184 | 39 | 4 | 51ed1ebfdef45149541917c66cbacad87072e51f | |
| ToppCell | COVID-19-kidney-Mito-rich_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.03e-05 | 185 | 39 | 4 | 1bbc2ba8a20f72f61981b1301cdd6018cdd9150d | |
| ToppCell | ILEUM-inflamed-(7)_Lymphatics|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.03e-05 | 185 | 39 | 4 | d711dd2e91cfee723dae1ccb2b910b8cf3becc3b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-05 | 186 | 39 | 4 | 8287146f0ba415ea04475588117d4668ae00f75c | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Endothelial-lymphatic_endothelial|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.08e-05 | 186 | 39 | 4 | 9d250d5ae7cf9129be05b41d70cb6c3a046c5f1e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.12e-05 | 187 | 39 | 4 | f1356273bd3587b6883295edf15cb9cdb706c057 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.12e-05 | 187 | 39 | 4 | 3ae3b8de1a195d4d5057cf3c64fcdb5f48681ce5 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.12e-05 | 187 | 39 | 4 | 71eb26ebf60cb0848e5bf1cd01edccda621aecd8 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.12e-05 | 187 | 39 | 4 | dcf6475ece5b34d9d58a0d1f51c18acedb19c119 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.17e-05 | 188 | 39 | 4 | f3edcefeef2ce19086032d98b243c02a6d542b38 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.17e-05 | 188 | 39 | 4 | 0792432cd4c564dea1102241ea9884f7ced7658c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-05 | 189 | 39 | 4 | 13fd07cc408a9486f61a7b2c3a132c52d14b438d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-05 | 189 | 39 | 4 | 204ab61ae606b2d9be0cb6bf6a83a011740693a8 | |
| ToppCell | normal_Lung-Endothelial_cells-Lymphatic_ECs|normal_Lung / Location, Cell class and cell subclass | 2.26e-05 | 190 | 39 | 4 | 2185db6007404a2b22325f91460dd17635be9bba | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.30e-05 | 191 | 39 | 4 | 361b123c8289015206d5e706ab2c615d9a724179 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial-lymphatic_endothelial|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.30e-05 | 191 | 39 | 4 | 011dc22c488369734749e839d65d52fe46b6a1a4 | |
| ToppCell | ILEUM-inflamed-(7)_Endothelial_cell-(7)_Lymphatics|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.35e-05 | 192 | 39 | 4 | d43caf42ec744e895137f31ef65a990e250669d2 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T8|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.35e-05 | 192 | 39 | 4 | e785135262f4c9cc66c403bf362bb34643b212c5 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 2.35e-05 | 192 | 39 | 4 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.40e-05 | 193 | 39 | 4 | bd0027fa97de41ae22ff64a61c8e217496f122ca | |
| ToppCell | distal-2-Endothelial-Lymphatic|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.50e-05 | 195 | 39 | 4 | 8e0f67a67af3bc0b16f48a621f74540f136383b7 | |
| ToppCell | distal-Endothelial-Lymphatic-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.50e-05 | 195 | 39 | 4 | f45c1349932ee7eb419cced8a4fdedae3610953f | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.55e-05 | 196 | 39 | 4 | 4ebcaac758ed01d918de9c1cd383a84457b615f3 | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.65e-05 | 198 | 39 | 4 | 306e28d31fd587409a12dcccc6b2abd7dc9c2e0a | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_lymphatic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.65e-05 | 198 | 39 | 4 | 05429f18e1d74880c1835568c86177f661b3477a | |
| ToppCell | Parenchymal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_systemic_venous|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.71e-05 | 199 | 39 | 4 | d62a2cb81b01ae59969e0b2bbe99c1c9cc96fdaa | |
| ToppCell | Tracheal-10x3prime_v2-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.76e-05 | 200 | 39 | 4 | 35f6c7f2469d12748c27f2a5d4a161ef839b4a07 | |
| ToppCell | Tracheal-10x3prime_v2-Endothelial-Endothelia_lymphatic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.76e-05 | 200 | 39 | 4 | b515b2ab0c3f5928dd67f2f227fc932451c272bb | |
| ToppCell | COVID-19-kidney-Epithelial_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.54e-04 | 119 | 39 | 3 | 7cde7c73bb71f5e1911706e51c2ea6dcc72930ac | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_3|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.04e-04 | 131 | 39 | 3 | aeeb5718b3a7122492ad2659d5c8112f60839ff3 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.43e-04 | 139 | 39 | 3 | a1945b07f177cde40e7eea03a19236ce76165857 | |
| ToppCell | COVID-19-kidney-Lymphatic_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.92e-04 | 148 | 39 | 3 | f777aa1674e898e2594b2b7c029d3d05dda04df9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.22e-04 | 153 | 39 | 3 | 499670e716fc85ce76630fc813cec86f8419f2a1 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Solid_Tissue_Normal|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 3.28e-04 | 154 | 39 | 3 | 89a60a79d07466d7ad05888d10a72d3b1ab384af | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Solid_Tissue_Normal-Connective_tissue_normal|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 3.28e-04 | 154 | 39 | 3 | f1fea1a87e977221fa125b62287368be9af4987d | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Solid_Tissue_Normal-Connective_tissue_normal-Connective_tissue_normal|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 3.28e-04 | 154 | 39 | 3 | b5604c0b0b9b283352a3f612f40883b9123475d1 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Solid_Tissue_Normal-Connective_tissue_normal-Connective_tissue_normal-1|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 3.28e-04 | 154 | 39 | 3 | 160b170a3ade8b246843c9854af332475c047ba0 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.81e-04 | 162 | 39 | 3 | c399b9e4854916a59f5cae2d8dbf19660f8759be | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.81e-04 | 162 | 39 | 3 | a291248b693c771845174393934a782f1d8bd7ce | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_4|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.81e-04 | 162 | 39 | 3 | 7d43d59531cbefe3ac94953b7faf7156b2a31441 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____proximal_tube_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.09e-04 | 166 | 39 | 3 | 8ab18c9d911eb3a9970bba7a769294b0927538f7 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 4.09e-04 | 166 | 39 | 3 | 6a6ed5c7a43fee9a8a9be42dfa99303815b8e8ef | |
| ToppCell | COVID-19-kidney-Lymphatic_EC|kidney / Disease (COVID-19 only), tissue and cell type | 4.16e-04 | 167 | 39 | 3 | 97d0fea1f41c1c00e36d9b5c4c1f0dd85087056f | |
| ToppCell | facs-Heart-LA-18m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.16e-04 | 167 | 39 | 3 | 8340f7075d00dccb304cfd4c9b5711ca6dbf7cce | |
| ToppCell | facs-Heart-LA-18m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.16e-04 | 167 | 39 | 3 | 8ce8d93c79ac6a3f52252b4cec53378c362bfe0a | |
| ToppCell | severe-CD4+_T_naive|severe / disease stage, cell group and cell class | 4.16e-04 | 167 | 39 | 3 | 02a8215fca59c357c1cdaa5738849eacf98c0bcc | |
| ToppCell | 368C-Fibroblasts-Fibroblast-C_(Myofibroblast)|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.23e-04 | 168 | 39 | 3 | 1bc6a1915d48f547385ed4f44e118bcc8a4a7b6c | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-epithelial_cell_of_proximal_tubule|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.23e-04 | 168 | 39 | 3 | dd48da83c32d41a62f80cd7e5e5c64e42776fa27 | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Rectum_normal_tissue-Rectum_normal_tissue-6|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 4.23e-04 | 168 | 39 | 3 | 5ce3129a023a48a3d7e6b9306c1fc5addfef9675 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.23e-04 | 168 | 39 | 3 | 69f534de0f9a293047bea03cb1b78551087a8df5 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.23e-04 | 168 | 39 | 3 | c66a61d3ec711796313a2c6d2dc39aedbfc20afd | |
| ToppCell | 368C-Fibroblasts-Fibroblast-C_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.23e-04 | 168 | 39 | 3 | 83b4f817d95daa15ae60668e789f97d8a3b2e6dd | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D122|Adult / Lineage, Cell type, age group and donor | 4.23e-04 | 168 | 39 | 3 | 8c3e1e45b422813bcdfa4273b1167db649a312f5 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.23e-04 | 168 | 39 | 3 | 7abaddbcc55e44653d54aa15464266aa6bd5c9d2 | |
| ToppCell | facs-Kidney-nan-3m-Epithelial-epithelial_cell_of_proximal_tubule|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.31e-04 | 169 | 39 | 3 | 922086f218135b734b7d370b871923e50141edce | |
| ToppCell | facs-Kidney-nan-3m-Epithelial-epithelial_cell_of_proximal_tubule|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.31e-04 | 169 | 39 | 3 | ee27bcfe3f9a295ec5fb0a375d77d1050e5cbaad | |
| ToppCell | Endothelial-B-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 4.31e-04 | 169 | 39 | 3 | 8889c9e8af1ab0b093d57b69abd80b59b3461be9 | |
| ToppCell | Control-Epithelial_cells-Airway_basal|Control / group, cell type (main and fine annotations) | 4.46e-04 | 171 | 39 | 3 | 3965ced4be6db14265a90673502fceee425837ca | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.53e-04 | 172 | 39 | 3 | 03a0aff6b7971093a4347b5ed12546d78374c56f | |
| Drug | Sodium | 1.28e-05 | 84 | 39 | 4 | ctd:D012964 | |
| Drug | diosmetin | 1.35e-05 | 85 | 39 | 4 | CID005281612 | |
| Drug | AC1L4Q3K | 1.48e-05 | 28 | 39 | 3 | CID000161798 | |
| Drug | AC1NUTWC | 1.71e-05 | 4 | 39 | 2 | CID005460914 | |
| Drug | (+) -Levobunolol hydrochloride [47141-41-3]; Down 200; 12.2uM; PC3; HT_HG-U133A | 1.99e-05 | 195 | 39 | 5 | 6635_DN | |
| Drug | Heptaminol hydrochloride [543-15-7]; Up 200; 22uM; PC3; HT_HG-U133A | 2.09e-05 | 197 | 39 | 5 | 1825_UP | |
| Drug | Roxarsone [121-19-7]; Down 200; 15.2uM; MCF7; HT_HG-U133A | 2.14e-05 | 198 | 39 | 5 | 5470_DN | |
| Drug | estradiol, USP; Down 200; 0.01uM; MCF7; HT_HG-U133A | 2.19e-05 | 199 | 39 | 5 | 7000_DN | |
| Drug | Saquinavir mesylate [149845-06-7]; Up 200; 5.2uM; MCF7; HT_HG-U133A | 2.25e-05 | 200 | 39 | 5 | 6246_UP | |
| Drug | D01432 | 5.97e-05 | 7 | 39 | 2 | CID011954228 | |
| Drug | salicylamide | 5.97e-05 | 7 | 39 | 2 | ctd:C031060 | |
| Drug | nifedipine | 6.93e-05 | 415 | 39 | 6 | CID000004485 | |
| Drug | 2-amino-1-methyl-6-(4-hydroxyphenyl)imidazo(4,5-b)pyridine | 7.95e-05 | 8 | 39 | 2 | ctd:C077584 | |
| Drug | ML3403 | 7.95e-05 | 8 | 39 | 2 | CID006419739 | |
| Drug | N-(2-(3H-indol-3-yl)ethyl)-9-isopropyl-2-(5-methyl-3-pyridyl)purin-6-amine | 7.95e-05 | 8 | 39 | 2 | ctd:C560625 | |
| Drug | Triamterene | 7.95e-05 | 8 | 39 | 2 | ctd:D014223 | |
| Drug | AhR antagonist | 9.69e-05 | 52 | 39 | 3 | CID003091786 | |
| Drug | azoxystrobin | 1.02e-04 | 9 | 39 | 2 | ctd:C087670 | |
| Drug | hypaconitine | 1.28e-04 | 10 | 39 | 2 | ctd:C058309 | |
| Drug | aroclor 1260 | 1.49e-04 | 60 | 39 | 3 | ctd:C026987 | |
| Drug | 4-chloro-2-methylphenoxyacetic acid | 1.56e-04 | 11 | 39 | 2 | CID000007204 | |
| Drug | tryptophan-P-1 | 1.64e-04 | 62 | 39 | 3 | CID005232175 | |
| Drug | Russian VX | 1.64e-04 | 62 | 39 | 3 | CID000178033 | |
| Drug | sodium | 1.66e-04 | 944 | 39 | 8 | CID000000923 | |
| Drug | desmethylclomipramine | 1.87e-04 | 12 | 39 | 2 | CID000622606 | |
| Drug | propachlor | 2.20e-04 | 13 | 39 | 2 | CID000004931 | |
| Drug | disuccinimidyloxalate | 2.20e-04 | 13 | 39 | 2 | CID005004084 | |
| Drug | salicyluric acid | 2.20e-04 | 13 | 39 | 2 | CID000010253 | |
| Drug | cimetidine | 2.45e-04 | 179 | 39 | 4 | CID000002756 | |
| Drug | AC1L1TSE | 2.55e-04 | 72 | 39 | 3 | CID000060719 | |
| Drug | DX-8951f | 2.57e-04 | 14 | 39 | 2 | CID000151114 | |
| Drug | N-(p-amylcinnamoyl)anthranilic acid | 2.57e-04 | 14 | 39 | 2 | CID000001974 | |
| Drug | Acurea | 2.88e-04 | 75 | 39 | 3 | CID000003662 | |
| Drug | phenylacetylglutamine | 2.96e-04 | 15 | 39 | 2 | CID000092258 | |
| Drug | MX100 | 2.96e-04 | 15 | 39 | 2 | CID000513956 | |
| Drug | Cesium | 2.96e-04 | 15 | 39 | 2 | ctd:D002586 | |
| Drug | tanshinone | 2.96e-04 | 15 | 39 | 2 | CID000114917 | |
| Drug | Clomipramine hydrochloride [17321-77-6]; Down 200; 11.4uM; PC3; HT_HG-U133A | 3.20e-04 | 192 | 39 | 4 | 4487_DN | |
| Drug | nisoldipine | 3.23e-04 | 78 | 39 | 3 | CID000004499 | |
| Drug | Acetylsalicylsalicylic acid [530-75-6]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 3.33e-04 | 194 | 39 | 4 | 6778_DN | |
| Drug | alpha-estradiol; Down 200; 0.01uM; MCF7; HT_HG-U133A_EA | 3.33e-04 | 194 | 39 | 4 | 990_DN | |
| Drug | 2-Chloropyrazine [14508-49-7]; Down 200; 35uM; MCF7; HT_HG-U133A | 3.33e-04 | 194 | 39 | 4 | 3570_DN | |
| Drug | 9,10-Dimethyl-1,2-benzanthracene | 3.33e-04 | 1046 | 39 | 8 | ctd:D015127 | |
| Drug | butalbital | 3.38e-04 | 16 | 39 | 2 | CID000002481 | |
| Drug | Trifluridine [70-00-8]; Up 200; 13.6uM; PC3; HT_HG-U133A | 3.39e-04 | 195 | 39 | 4 | 5819_UP | |
| Drug | Retinoic acid [302-79-4]; Up 200; 13.4uM; PC3; HT_HG-U133A | 3.46e-04 | 196 | 39 | 4 | 5767_UP | |
| Drug | Benzonatate [104-31-4]; Down 200; 6.6uM; HL60; HT_HG-U133A | 3.46e-04 | 196 | 39 | 4 | 1843_DN | |
| Drug | Furaltadone hydrochloride [3759-92-0]; Up 200; 11uM; MCF7; HT_HG-U133A | 3.53e-04 | 197 | 39 | 4 | 3413_UP | |
| Drug | Serotonin hydrochloride [153-98-0]; Down 200; 18.8uM; PC3; HT_HG-U133A | 3.53e-04 | 197 | 39 | 4 | 4673_DN | |
| Drug | Piperacetazine [3819-00-9]; Down 200; 9.8uM; PC3; HT_HG-U133A | 3.53e-04 | 197 | 39 | 4 | 5834_DN | |
| Drug | Isotretinoin [4759-48-2]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 3.53e-04 | 197 | 39 | 4 | 6017_DN | |
| Drug | Benzthiazide [91-33-8]; Down 200; 9.2uM; PC3; HT_HG-U133A | 3.53e-04 | 197 | 39 | 4 | 6607_DN | |
| Drug | Cefepime hydrochloride [123171-59-5]; Up 200; 7.4uM; PC3; HT_HG-U133A | 3.53e-04 | 197 | 39 | 4 | 5761_UP | |
| Drug | Cefuroxime sodium salt [56238-63-2]; Up 200; 9uM; PC3; HT_HG-U133A | 3.53e-04 | 197 | 39 | 4 | 5787_UP | |
| Drug | Amyleine hydrochloride [532-59-2]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 3.53e-04 | 197 | 39 | 4 | 1491_UP | |
| Drug | haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A | 3.60e-04 | 198 | 39 | 4 | 1669_DN | |
| Drug | Tridihexethyl chloride; Down 200; 11.4uM; MCF7; HT_HG-U133A | 3.60e-04 | 198 | 39 | 4 | 5486_DN | |
| Drug | Methiothepin maleate [19728-88-2]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 3.60e-04 | 198 | 39 | 4 | 5413_DN | |
| Drug | Loracarbef [121961-22-6]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 3.60e-04 | 198 | 39 | 4 | 5492_DN | |
| Drug | Tranexamic acid [1197-18-8]; Down 200; 25.4uM; PC3; HT_HG-U133A | 3.60e-04 | 198 | 39 | 4 | 2085_DN | |
| Drug | (1)-Nipecotic acid [498-95-3]; Down 200; 31uM; PC3; HT_HG-U133A | 3.60e-04 | 198 | 39 | 4 | 7296_DN | |
| Drug | Ketoprofen [22071-15-4]; Up 200; 15.8uM; PC3; HT_HG-U133A | 3.60e-04 | 198 | 39 | 4 | 4286_UP | |
| Drug | Lisuride (S)(-) [18016-80-3]; Up 200; 11.8uM; PC3; HT_HG-U133A | 3.60e-04 | 198 | 39 | 4 | 6682_UP | |
| Drug | Tinidazole [19387-91-8]; Down 200; 16.2uM; PC3; HT_HG-U133A | 3.67e-04 | 199 | 39 | 4 | 3813_DN | |
| Drug | Spectinomycin dihydrochloride [21736-83-4]; Down 200; 9.8uM; HL60; HT_HG-U133A | 3.67e-04 | 199 | 39 | 4 | 2987_DN | |
| Drug | gadolinium | 3.67e-04 | 199 | 39 | 4 | CID000023982 | |
| Drug | Vidarabine [5536-17-4]; Down 200; 15uM; MCF7; HT_HG-U133A | 3.67e-04 | 199 | 39 | 4 | 7203_DN | |
| Drug | Naphazoline hydrochloride [550-99-2]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 3.67e-04 | 199 | 39 | 4 | 1466_DN | |
| Drug | Streptozotocin [18883-66-4]; Up 200; 15uM; HL60; HT_HG-U133A | 3.67e-04 | 199 | 39 | 4 | 2535_UP | |
| Drug | Ranitidine hydrochloride [66357-59-3]; Down 200; 11.4uM; PC3; HT_HG-U133A | 3.67e-04 | 199 | 39 | 4 | 6324_DN | |
| Drug | Fluvoxamine maleate [61718-82-9]; Down 200; 9.2uM; HL60; HT_HG-U133A | 3.67e-04 | 199 | 39 | 4 | 2913_DN | |
| Drug | Clindamycin hydrochloride [21462-39-5]; Down 200; 8.6uM; PC3; HT_HG-U133A | 3.67e-04 | 199 | 39 | 4 | 2057_DN | |
| Drug | Esculin Hydrate [531-75-9]; Down 200; 11.8uM; HL60; HT_HG-U133A | 3.74e-04 | 200 | 39 | 4 | 3052_DN | |
| Drug | Hydrocotarnine hydrobromide [5985-00-2]; Down 200; 13.2uM; PC3; HT_HG-U133A | 3.74e-04 | 200 | 39 | 4 | 4489_DN | |
| Drug | D-myo-inositol-1,4,5-triphosphate | 3.80e-04 | 568 | 39 | 6 | CID000000806 | |
| Drug | musk xylene | 3.83e-04 | 17 | 39 | 2 | CID000062329 | |
| Disease | X-21319 measurement | 1.70e-06 | 2 | 39 | 2 | EFO_0800807 | |
| Disease | serum metabolite measurement | 3.05e-06 | 945 | 39 | 9 | EFO_0005653 | |
| Disease | X-11478 measurement | 5.10e-06 | 3 | 39 | 2 | EFO_0021242 | |
| Disease | 3-hydroxyhexanoate measurement | 1.70e-05 | 5 | 39 | 2 | EFO_0800378 | |
| Disease | indoleacetoylcarnitine measurement | 2.54e-05 | 6 | 39 | 2 | EFO_0800106 | |
| Disease | Lymphopenia | 3.56e-05 | 7 | 39 | 2 | C0024312 | |
| Disease | MASA syndrome (implicated_via_orthology) | 3.56e-05 | 7 | 39 | 2 | DOID:0060246 (implicated_via_orthology) | |
| Disease | facial depth measurement | 6.09e-05 | 9 | 39 | 2 | EFO_0007857 | |
| Disease | paraxanthine measurement | 1.11e-04 | 12 | 39 | 2 | EFO_0021178 | |
| Disease | coffee consumption, cups of coffee per day measurement | 2.02e-04 | 16 | 39 | 2 | EFO_0004330, EFO_0006782 | |
| Disease | diabetes mellitus (biomarker_via_orthology) | 2.87e-04 | 19 | 39 | 2 | DOID:9351 (biomarker_via_orthology) | |
| Disease | acute myocardial infarction (biomarker_via_orthology) | 6.30e-04 | 28 | 39 | 2 | DOID:9408 (biomarker_via_orthology) | |
| Disease | Global developmental delay | 7.27e-04 | 133 | 39 | 3 | C0557874 | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 9.71e-04 | 147 | 39 | 3 | DOID:9352 (biomarker_via_orthology) | |
| Disease | facial emotion recognition measurement | 9.85e-04 | 35 | 39 | 2 | EFO_0008329 | |
| Disease | Focal glomerulosclerosis | 1.04e-03 | 36 | 39 | 2 | C0017668 | |
| Disease | cups of coffee per day measurement | 1.29e-03 | 40 | 39 | 2 | EFO_0006782 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MLDMGFGPEMKKLIS | 451 | Q9NQI0 | |
| LEMSLKMYGMGPRLY | 521 | Q15878 | |
| MVSKTMKIKPGYMGT | 371 | Q08AH3 | |
| MLGLKPKADAFFVMM | 496 | Q9UNQ0 | |
| MGMVKIFSGRKPMLY | 151 | P50416 | |
| MYVIDLMFHPGGLMK | 846 | Q5W041 | |
| DGKGIYLQKPEWMMM | 666 | A8MX76 | |
| NKPLSEKMMLFGMGK | 441 | P05177 | |
| YGKGKLLMDMALFMG | 1126 | P52948 | |
| GRGKIMPNSFIMMFK | 386 | Q9UKZ9 | |
| QIDKPMKMEKGEMYG | 711 | Q9NY74 | |
| PMYFMKLRSGLMIKK | 41 | O95760 | |
| IGKPVLGICYGMQMM | 96 | P49915 | |
| CLPLFMKMTKMGGLL | 111 | Q6VVX0 | |
| MKMTKMGGLLNSRYG | 116 | Q6VVX0 | |
| MPLAKDGLAMGKEMP | 61 | P27658 | |
| KYPTLKLFRNGMMMK | 106 | Q9BS26 | |
| ERMMKKGSLMLGYQP | 471 | Q6ZQY3 | |
| MMLIIGLNMLFGPKK | 356 | Q9H720 | |
| MDKLMMDKYPGIRQI | 406 | O95602 | |
| PGGDMMTLLMKKDTL | 171 | Q9Y2H1 | |
| KKGMLGMIVYLGMMA | 146 | Q7L1I2 | |
| LQGYDMLMNPKKMGE | 386 | Q7L592 | |
| ANLGMMGKVVYMPAL | 566 | Q96ME1 | |
| MGKVVYMPALSDMLK | 571 | Q96ME1 | |
| LGPKSMMKMLLDPMG | 41 | P49368 | |
| SDMMMKYMGLKLGPA | 631 | Q96GD3 | |
| YFGMKIVRVPLTKMM | 251 | O95470 | |
| MVSKTMKIKPGYMGT | 371 | Q68CK6 | |
| YLKMLPMGLIIMPGM | 306 | A0PJK1 | |
| DVMMKYMGLKLGPAL | 671 | Q9UQR0 | |
| NKYLGPYVMMIGKMM | 1016 | Q9HCF6 | |
| GMPNGYRKEMIKIPM | 106 | Q86VZ5 | |
| YLGPYVMMIGKMMID | 951 | Q7Z4N2 | |
| KLFGMDPMADYMLLM | 146 | O43435 | |
| KMGKIMRGPFMKFVA | 431 | Q9Y210 | |
| IGNLMYGVVKLMKIM | 226 | Q96T83 | |
| LCGYLKLMPMFIMVM | 316 | P13866 | |
| DMVMKYLGLKLGPAL | 386 | Q8N228 | |
| AGPKMMGLGLMAKDK | 241 | P41229 | |
| YLVMPFMGTDLGKLM | 106 | P53778 |